Abstract:<p>Protein ubiquitylation regulates almost all aspects of the biological processes including gene expression, DNA repair, cell proliferation and apoptosis in eukaryotic cells. Dysregulation of protein ubiquitylation caused by abnormal expression of enzymes in the ubiquitin system results in the onset of many diseases including cancer, neurodegenerative diseases, and metabolic syndromes. Therefore, targeting the ubiquitin system becomes a promising research area in drug discovery. Identification of protein ubiquitylation sites is critical for revealing the key ubiquitylation events associated with diseases and specific signaling pathways and for elucidating the biological functions of the specific ubiquitylation events. Many approaches that enrich for the ubiquitylated proteins and ubiquitylated peptides at the protein and peptide levels have been developed to facilitate their identification by MS. In this paper, we will review the proteomic approaches available for the identification of ubiquitylation events at the proteome scale and discuss their advantages and limitations. We will also brief the application of the profiling of ubiquitylation events in drug target discovery and in target validation for proteolysis-targeting chimera (PROTAC). Possible future research directions in this field will also be discussed.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Significance</h3><p>Ubiquitylation plays critical roles in regulating many biological processes in eukaryotic cells. Identification of ubiquitylation sites can provide the essential information for the functional study of the specific modified substrates. Since ubiquitylated proteins have much lower abundance than non-ubiquitylated proteins, enrichment of ubiquitylated proteins or peptides is critical for their identification by MS. This review focuses on different enrichment approaches that facilitate their isolation and identification by MS and discusses the advantages and drawbacks of these approaches. The application of the profiling of ubiquitylation events in drug target discovery and future research directions will be beneficial to the research community.</p>

Using proteomics to identify ubiquitin ligase–substrate pairs: how novel methods may unveil therapeutic targets for neurodegenerative diseases

Ubiquitin E3 ligases assisted technologies in protein degradation: Sharing Pathways in Neurodegenerative Disorders and Cancer

Ubiquitin-specific proximity labeling for the identification of E3 ligase substrates

Integrative Proximal-Ubiquitomics Profiling for Deubiquitinase and E3 Ligase Substrate Discovery Applied to USP30

A ubiquitin-specific, proximity-based labeling approach for the identification of ubiquitin ligase substrates

A Proteomics Strategy to Identify Substrates of LNX, a PDZ Domain Containing E3 Ubiquitin Ligase

High‐Throughput Discovery of Substrate Peptide Sequences for E3 Ubiquitin Ligases Using a cDNA Display Method

A method to identify small molecule/protein pairs susceptible to protein ubiquitination

Targeted Modulation of E3 Ligases Using Engineered Ubiquitin Variants.

Comprehensive Profiling of Protein Ubiquitination for Drug Discovery

Time-resolved in vivo ubiquitinome profiling by DIA-MS reveals USP7 targets on a proteome-wide scale

Proteomic approaches for the profiling of ubiquitylation events and their applications in drug discovery

Targeted Degradation of 53BP1 Using Ubiquitin Variant Induced Proximity

Abstract 3885: A ubiquitin-specific proximity labeling method to study drug-induced ubiquitylation

Defining E3 ligase–substrate relationships through multiplex CRISPR screening

Generating Intracellular Modulators of E3 Ligases and Deubiquitinases from Phage-Displayed Ubiquitin Variant Libraries.

Specific Substrate Recognition and Thioester Intermediate Determinations in Ubiquitin and Sumo Conjugation Cascades Revealed by A High-Sensitive Fret Assay

Investigating Protein Degradability through Site-Specific Ubiquitin Ligase Recruitment

Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications

Design of linked-domain protein inhibitors of UBE2D as tools to study cellular ubiquitination

Proteomic identification of protein ubiquitination events